Why Diuresis Occurs After Starting Prednisolone in Nephrotic Syndrome
Prednisolone induces diuresis in nephrotic syndrome by reducing proteinuria and restoring oncotic pressure, which mobilizes edema fluid back into the vascular space for renal excretion. This is the primary therapeutic mechanism listed in FDA labeling, which explicitly indicates prednisolone "to induce diuresis or remission of proteinuria in nephrotic syndrome" 1.
Mechanism of Action
The diuretic effect occurs through several interconnected pathways:
Primary Mechanism: Reduction of Proteinuria
- Prednisolone suppresses the underlying glomerular inflammation that causes protein leakage, particularly in steroid-sensitive nephrotic syndrome
- As proteinuria decreases, serum albumin levels rise, restoring plasma oncotic pressure
- This oncotic pressure gradient pulls interstitial edema fluid back into the vascular compartment
- The kidneys then excrete this mobilized fluid, producing diuresis
Renal Hemodynamic Effects
Prednisolone has direct effects on kidney function that contribute to diuresis 1:
- Increases glomerular filtration rate (GFR) through its glucocorticoid properties
- Enhances urinary excretion of urate while maintaining stable creatinine excretion
- Increases calcium excretion
Mineralocorticoid Activity
Despite being primarily a glucocorticoid, prednisolone has "slight mineralocorticoid activity" 1 that paradoxically can contribute to the overall fluid balance normalization as the disease improves.
Important Clinical Caveat: The Acute Paradox
A critical pitfall to recognize: In the first 24-48 hours after prednisolone administration, proteinuria may actually increase before it decreases 2, 3, 4. This occurs because:
- Prednisolone acutely increases glomerular permeability to proteins by changing size selectivity of the glomerular barrier 2, 3
- GFR increases from baseline (83 ml/min) to higher levels (95 ml/min) within 5 hours, raising filtration fraction and glomerular pressure 2
- This creates a transient worsening of proteinuria (from ~6.7 to ~9.4 mg/min) 2
However, this acute increase does not prevent the subsequent therapeutic effect. The anti-inflammatory action over days to weeks ultimately reduces proteinuria and induces remission, leading to diuresis.
Timeline of Response
Based on guideline-recommended dosing 5, 6:
- Remission typically occurs within 4-6 weeks of initiating prednisolone therapy at 2 mg/kg/day (or 60 mg/m²/day)
- Time to remission averages around 9 days in many patients 7
- Diuresis becomes clinically apparent as remission approaches and proteinuria decreases
- All patients in controlled trials achieved remission with appropriate dosing 8
Clinical Application
When starting prednisolone for nephrotic syndrome:
- Expect diuresis to follow remission of proteinuria, not to occur immediately
- Monitor for the acute paradoxical increase in proteinuria in the first 1-2 days—this is expected and does not indicate treatment failure
- The diuretic effect reflects successful disease control rather than a direct diuretic action of the drug
- Neither ACE inhibitors nor prostaglandin inhibitors affect this prednisolone-induced proteinuria pattern 2
The diuresis is fundamentally a marker of therapeutic success—as the glomerular disease responds to immunosuppression, protein loss stops, oncotic pressure normalizes, and accumulated edema resolves through natural renal excretion.